Christopher Silber - 07 Aug 2023 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Chief Medical Officer
Signature
/s/ Christopher Verni, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
07 Aug 2023
Net transactions value
$0
Form type
4
Filing time
07 Aug 2023, 18:43:55 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +330,000 $0.000000 330,000 07 Aug 2023 Common Stock 330,000 $6.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on August 7, 2024 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.